MedPath

The effect of spearmint-ginger capsule on ?incidence and severity of oral mucositis

Phase 3
Conditions
Breast cancer patients.
Malignant neoplasm of breast
Registration Number
IRCT20180215038741N2
Lead Sponsor
Sanandaj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
70
Inclusion Criteria

History of at least one course of chemotherapy
Definitive diagnosis of breast cancer by clinical trials and an oncologist

Exclusion Criteria

Having a history of allergy to ginger or mint and taking them over the past week
Metastasis to other organs of other body systems

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Occurrence of mucositis, severity of mucositis. Timepoint: The first day of chemotherapy, five days after chemotherapy, ten days after chemotherapy, fourteen days after chemotherapy. Method of measurement: A questionnaire, an information recording form and Oral Health Index (OHI).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath